Debating Genomic Viability
This article was originally published in Start Up
Executive Summary
Genomics firms are hot on Wall Street now, but are they built to last? Experts debated the matter at Windhover's Pharmaceutical Strategic Alliances conference in New York City last month. Panelists considered questions such as: what sorts of things--not just genes, but Internet business methods--are patentable, and how long will they be?